MMP-7 Modulation by Short and Long Term Radiotherapy in Rectal Cancer Patients

NCT ID: NCT03151759

Last Updated: 2017-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

77 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-11-06

Study Completion Date

2007-03-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To analyse the effects of radiation therapy on inflammation and matrilysin levels in rectal cancer patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No radiotherapy

Surgery only

No interventions assigned to this group

25 Gray radiotherapy

Surgery after short term radiotherapy

Neoadjuvant radiotherapy

Intervention Type RADIATION

Neoadjuvant radiotherapy prior to rectal cancer surgery

50 Gray radiotherapy

Surgery after long term radiotherapy

Neoadjuvant radiotherapy

Intervention Type RADIATION

Neoadjuvant radiotherapy prior to rectal cancer surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neoadjuvant radiotherapy

Neoadjuvant radiotherapy prior to rectal cancer surgery

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adenocarcinoma of the rectum, ability to understand written and oral information, written consent.

Exclusion Criteria

Colon cancer, benign tumors, impaired general condition of patient, declining to participate in the study, synchronous colonic tumors, logistical reasons, inability to understand written and/or oral information, previous pelvic irradiation, ongoing immunosuppressive therapy, diabetes with systemic complications.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Skane

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LU155-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immunoscore in Rectal Cancer
NCT02017509 COMPLETED